Vaccine Development Excellence
Strategy & Feasibility
Roadmap + Investment Logic
Best for: Concept stage, early investment decisions, portfolio planning, or "we need clarity before CAPEX"
Comprehensive testing options
Expert analysis
Timely reporting
Patient-focused approach
Typical Outcomes
Receive detailed reports that guide treatment decisions.
Clear Product/Platform Pathway
Defined strategy and direction for your vaccine development
Budget & Timeline Confidence
Realistic projections for investment planning and milestones
Early Identification of Show-Stoppers
Critical risks and technical challenges addressed upfront
Deliverables
You will receive comprehensive microbiology reports.
Process Flow & Facility Concept
High-level process design and facility layout notes
Feasibility Report
Platform + manufacturing pathway analysis
Target Product Profile / CMC Outline
High-level product definition and CMC strategy
CAPEX/OPEX Assumptions
Financial scenario modeling and cost estimates
Risk Register (QRM)
Quality Risk Management with mitigation roadmap
Vendor Landscape Shortlisting
Equipment and consumables supplier recommendations
Platforms We Support
Accessible through various healthcare platforms.
Baculovirus / VLP
Virus-like particle platforms
Used in:
Human
Vet
Typical Risks / Bottlenecks
- Lot-to-lot consistency
- Complex impurity profile (baculovirus, host proteins)
- Scale-up challenges (cell density, MOI)
- Analytical method development (empty vs full VLP)
What We Do
- Upstream strategy (insect cell platform, MOI optimization)
- DSP train design (clarification, chromatography, TFF)
- Analytical method map (EM, SEC, potency)
- Tech transfer from R&D to pilot/commercial
Typical Deliverables
Upstream process optimization plan
DSP flowsheet & unit operation selection
Analytical control strategy
Tech transfer package & training
mRNA / LNP
Advisory support
Used in:
Human
Vet
Typical Risks / Bottlenecks
- Supply chain (lipids, enzymes)
- Complex analytics (size, encapsulation, integrity)
- Aseptic manufacturing strategy
- Cold chain logistics & stability
What We Do
- CMC roadmap & regulatory strategy
- Facility concept (isolators, aseptic)
- Vendor shortlist (lipids, CDMO)
- QA/QC readiness & analytics build
Typical Deliverables
Target Product Profile / CMC Outline
Feasibility Report
Industries
Catering to healthcare providers and individual patients.
Human Vaccines
Typical Projects
- Supply chain (lipids, enzymes)
- Complex analytics (size, encapsulation, integrity)
- Aseptic manufacturing strategy
- Cold chain logistics & stability
What Success Looks Like
- Expression platform comparison & selection
- Upstream & downstream integration
- Formulation & adjuvant compatibility
- Stability & aggregation risk mitigation
Common Pitfalls
- Supply chain (lipids, enzymes)
- Complex analytics (size, encapsulation, integrity)
- Aseptic manufacturing strategy
- Cold chain logistics & stability
Cost-of-goods
Cost-of-goods
Cost-of-goods
Cost-of-goods
Human Vaccines
Insights & Resources
Industry expertise, best practices, and thought leadership in vaccine development
Add-on Services
Consultations available for further guidance.
GMP Gap Assessment & CAPA Package
Audit response support, CAPA table, risk assessment outline, evidence plan
Deliverables
- Gap report
- CAPA register
- Risk assessment outline
- Evidence package
Operational Excellence for Vaccine Plants
Deviation reduction, line clearance logic, scheduling to reduce mix-ups, KPI dashboards
Deliverables
- Gap report
- CAPA register
- Risk assessment outline
- Evidence package
Training (Production / QC / QA / Engineering)
Tailored workshops with templates, quizzes, and 'audit-friendly' outputs
Deliverables
- Gap report
- CAPA register
- Risk assessment outline
- Evidence package
What we need from you
Samples and relevant medical history.
Discovery & Data Request
Understanding your context
- Clarify product/project goals, platform constraints, current maturity level
- Request minimum data needed to act
Gap assessment / Risk-Based Roadmap (QRM/CCS)
Risk mapping and prioritization
- Identify critical risks (contamination, mix-ups, segregation gaps, utilities, validation readiness)
- Turn risks into a practical plan
Implementation Deliverables
Risk mapping and prioritization
- URS packages, layouts/flows, SOP/MBR templates, CAPA tables, vendor inputs, FAT/SAT protocols
- Ready-to-use outputs
Verification & Readiness
Audit-ready handoff
- Support execution and verification logic
- Provide 'inspection-grade' documentation so the project can stand on its own
Let's discuss your vaccine project — from Lab to Jab.
Tell us what you're building and where you are today. We'll respond with the fastest path to a defensible plan.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Vaccine Development & Manufacturing Consulting
From concept to GMP-ready production
From concept to GMP-ready production
Confidential. No magic, no unrealistic timelines, no NDA breaches.
© 2026 FromLab2Jab. All rights reserved.
Design and developed by YAVACADO